FDA-Fuji Dream Airlines (Makinohara, Shizuoka) of Japan, has signed a contract for two Embraer ERJ 175 jets, in a ceremony held at the headquarters of the airlines’ parent company, Suzuyo Corporation in Shimizu, Japan. The total value of the deal is $81.6 million, at list prices, which will be included in Embraer’s fourth quarter of 2012 backlog. Both aircraft will be configured in a single-class layout with 84 seats. This order brings the total number of aircraft in the airline’s all-E-Jet fleet to eight.
These aircraft will be equipped with Autoland systems to perform CAT III approach and landing in limited visual conditions. This system assures on-time performance of aircraft and avoids diversions or delays due to weather. In line with FDA’s brand, each of these aircraft will be painted in a different color. The colors of the six E-Jets in the airline’s current fleet are red, light blue, green, orange, pink and purple (see below).
FDA is conducting an online contest to determine the color of its seventh Embraer E-Jet (see below – in Japanese):
Created in 2007 as a low-cost operator, FDA initially ordered two E170 jets for its start-up operations from Shizuoka in July 2009. In that same year, FDA ordered another E175, and subsequently added one E170 and two E175 jets between 2010 and 2011, thereby tripling its initial fleet in less than 3 years of revenue service.
With aircraft based in Nagoya and Shizuoka, FDA links secondary cities in Japan where demand is growing. The six E-Jets in FDA’s current fleet covers a network of 10 stations spread across Japan such as Fukuoka, Niigata, Aomori and Sapporo. The airline has carried over 1.3 million passengers to date. It operates 40 daily flights and has been doing so with an outstanding schedule reliability of 99.5% on average for the last 12 months.
Top Copyright Photo: Nobuhiro Horimoto. FDA-Fuji Dream Airlines’ Embraer ERJ 170-200STD (ERJ 175) JA05FJ (msn 17000317) lands at Matsumoto.